To quantify the hepatic transport of the hepatobiliary contrast agent gadobenate dimeglumine (Gd-BOPTA) in rats with biliary cirrhosis of various severity degrees from magnetic resonance (MR) signal intensities using a population pharmacokinetic approach
For drugs with hepatobiliary transport across hepatocytes, the interplay between uptake and efflux t...
In the liver, the accumulation of hepatobiliary contrast agents is a crucial issue to understand the...
During biliary cirrhosis in rats, organic anion-transporting peptides (Oatps) and ATP-dependent mult...
We sought to develop and validate a pharmacokinetic model allowing description of the magnetic reson...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers PLANCHA...
To investigate the transport of the hepatobiliary magnetic resonance (MR) imaging contrast agent Gd-...
Gd-BOPTA (gadobenate dimeglumine) is a magnetic resonance (MR) contrast agent that, after i.v. admin...
To compare in the entire liver, the hepatic kinetics of gadobenate dimeglumine (Gd-BOPTA) and gadope...
Following the injection of hepatobiliary contrast agents, MRI detects all molecules included in a re...
Drug-induced liver injury (DILI) is a clinically important adverse drug reaction, which prevents the...
Gadobenate dimeglumine (Gd-BOPTA) is a commercialised hepatobiliary contrast agent used during liver...
Drug-induced liver injury (DILI) is a leading cause of acute liver failure and transplantation. DILI...
Gadobenate dimeglumine (Gd-BOPTA) is a commercialised hepatobiliary contrast agent used during liver...
For drugs with hepatobiliary transport across hepatocytes, the interplay between uptake and efflux t...
In the liver, the accumulation of hepatobiliary contrast agents is a crucial issue to understand the...
During biliary cirrhosis in rats, organic anion-transporting peptides (Oatps) and ATP-dependent mult...
We sought to develop and validate a pharmacokinetic model allowing description of the magnetic reson...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers PLANCHA...
To investigate the transport of the hepatobiliary magnetic resonance (MR) imaging contrast agent Gd-...
Gd-BOPTA (gadobenate dimeglumine) is a magnetic resonance (MR) contrast agent that, after i.v. admin...
To compare in the entire liver, the hepatic kinetics of gadobenate dimeglumine (Gd-BOPTA) and gadope...
Following the injection of hepatobiliary contrast agents, MRI detects all molecules included in a re...
Drug-induced liver injury (DILI) is a clinically important adverse drug reaction, which prevents the...
Gadobenate dimeglumine (Gd-BOPTA) is a commercialised hepatobiliary contrast agent used during liver...
Drug-induced liver injury (DILI) is a leading cause of acute liver failure and transplantation. DILI...
Gadobenate dimeglumine (Gd-BOPTA) is a commercialised hepatobiliary contrast agent used during liver...
For drugs with hepatobiliary transport across hepatocytes, the interplay between uptake and efflux t...
In the liver, the accumulation of hepatobiliary contrast agents is a crucial issue to understand the...
During biliary cirrhosis in rats, organic anion-transporting peptides (Oatps) and ATP-dependent mult...